Luo P - Search Results

1

Large-Scale Single-Cell and Bulk Sequencing Analyses Reveal the Prognostic Value and Immune Aspects of CD147 in Pan-Cancer.

Zhang J, Wang Z, Zhang X, Dai Z, Zhi-Peng W, Yu J, Peng Y, Wu W, Zhang N, Luo P, Zhang J, Liu Z, Feng S, Zhang H, Cheng Q. Zhang J, et al. Among authors: luo p. Front Immunol. 2022 Apr 6;13:810471. doi: 10.3389/fimmu.2022.810471. eCollection 2022. Front Immunol. 2022. PMID: 35464411 Free PMC article.

2

Adjuvant chemoradiotherapy versus radiotherapy alone in high-risk endometrial cancer: A systematic review and meta-analysis.

Yi L, Zhang H, Zou J, Luo P, Zhang J. Yi L, et al. Among authors: luo p. Gynecol Oncol. 2018 Jun;149(3):612-619. doi: 10.1016/j.ygyno.2018.03.004. Epub 2018 Mar 9. Gynecol Oncol. 2018. PMID: 29530332 Review.

3

Systematic review and meta-analysis of the benefit of celecoxib in treating advanced non-small-cell lung cancer.

Yi L, Zhang W, Zhang H, Shen J, Zou J, Luo P, Zhang J. Yi L, et al. Among authors: luo p. Drug Des Devel Ther. 2018 Aug 7;12:2455-2466. doi: 10.2147/DDDT.S169627. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 30122902 Free PMC article.

4

The efficacy and safety of ALK inhibitors in the treatment of ALK-positive non-small cell lung cancer: A network meta-analysis.

Fan J, Fong T, Xia Z, Zhang J, Luo P. Fan J, et al. Among authors: luo p. Cancer Med. 2018 Oct;7(10):4993-5005. doi: 10.1002/cam4.1768. Epub 2018 Sep 19. Cancer Med. 2018. PMID: 30230699 Free PMC article.

5

Efficacy and Safety of Ipilimumab plus Chemotherapy for Advanced Lung Cancer: A Systematic Review and Meta-Analysis.

Zhang H, Shen J, Yi L, Zhang W, Luo P, Zhang J. Zhang H, et al. Among authors: luo p. J Cancer. 2018 Nov 11;9(23):4556-4567. doi: 10.7150/jca.27368. eCollection 2018. J Cancer. 2018. PMID: 30519362 Free PMC article.

6

Efficacy and safety of osimertinib in treating EGFR-mutated advanced NSCLC: A meta-analysis.

Yi L, Fan J, Qian R, Luo P, Zhang J. Yi L, et al. Among authors: luo p. Int J Cancer. 2019 Jul 1;145(1):284-294. doi: 10.1002/ijc.32097. Epub 2019 Jan 20. Int J Cancer. 2019. PMID: 30613959 Free PMC article.

7

Efficacy and safety of selective internal radiotherapy versus sorafenib for intermediate-locally advanced hepatocellular carcinoma: a systematic review and meta-analysis.

Zou J, Zhu W, Meng H, Luo P, Zhang J. Zou J, et al. Among authors: luo p. Expert Rev Gastroenterol Hepatol. 2019 Mar;13(3):271-279. doi: 10.1080/17474124.2019.1570135. Epub 2019 Jan 25. Expert Rev Gastroenterol Hepatol. 2019. PMID: 30791765

8

Author's Reply to: Osimertinib and jaw osteonecrosis? A case report.

Yi L, Luo P, Zhang J. Yi L, et al. Among authors: luo p. Int J Cancer. 2019 Oct 1;145(7):2006-2007. doi: 10.1002/ijc.32398. Epub 2019 May 10. Int J Cancer. 2019. PMID: 31074838 No abstract available.

9

Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.

Yi L, Luo P, Zhang J. Yi L, et al. Among authors: luo p. J Cell Biochem. 2019 Sep;120(9):16229-16243. doi: 10.1002/jcb.28904. Epub 2019 May 12. J Cell Biochem. 2019. PMID: 31081184

10

Comparison of the incidence of colorectal cancer in young adults between the USA and Europe.

Wei T, Luo P, Zhang X, Zhu W, Zhang J. Wei T, et al. Among authors: luo p. Gut. 2020 Aug;69(8):1540-1542. doi: 10.1136/gutjnl-2019-319391. Epub 2019 Jul 31. Gut. 2020. PMID: 31366454 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,947 results

Search Page

Filters